Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 455

The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.

Global evolution of inflammatory bowel disease across epidemiologic stages

Open access
Hracs, Lindsay, Windsor, Joseph W., Gorospe, Julia, Cummings, Michael, Coward, Stephanie, Buie, Michael J., Quan, Joshua, Goddard, Quinn, Caplan, Léa, Markovinović, Ante, Williamson, Tyler, Abbey, Yvonne, Abdullah, Murdani, Abreu, Maria T., Ahuja, Vineet, Raja Ali, Raja Affendi, Altuwaijri, Mansour, Balderramo, Domingo, Banerjee, Rupa, Benchimol, Eric I., Bernstein, Charles N., Brunet-Mas, Eduard, Burisch, Johan, Chong, Vui Heng, Dotan, Iris, Dutta, Usha, El Ouali, Sara, Forbes, Angela, Forss, Anders, Gearry, Richard, Dao, Viet Hang, Hartono, Juanda Leo, Hilmi, Ida, Hodges, Phoebe, Jones, Gareth-Rhys, Juliao-Baños, Fabián, Kaibullayeva, Jamilya, Kelly, Paul, Kobayashi, Taku, Kotze, Paulo Gustavo, Lakatos, Peter L., Lees, Charlie W., Limsrivilai, Julajak, Lo, Bobby, Loftus, Edward V., Ludvigsson, Jonas F., Mak, Joyce W. Y., Miao, YingLei, Ng, Ka Kei, Okabayashi, Shinji, Olén, Ola, Panaccione, Remo, Paudel, Mukesh Sharma, Quaresma, Abel Botelho, Rubin, David T., Simadibrata, Marcellus, Sun, Yang, Suzuki, Hidekazu, Toro, Martin, Turner, Dan, Iade, Beatriz, Wei, Shu Chen, Yamamoto-Furusho, Jesus K., Yang, Suk-Kyun, Ng, Siew C., Kaplan, Gilaad G., Global IBD Visualization of Epidemiology Studies in the 21st Century (GIVES-21) Research Group · 2025 · Nature

Abstract

During the twentieth century, inflammatory bowel disease (IBD) was considered a disease of early industrialized regions in North America, Europe and Oceania1. At the turn of the twenty-first century, IBD incidence increased in newly industrialized and emerging regions in Africa, Asia and Latin America, while the prevalence in early industrialized regions continued to grow steadily2–4. Changes in the incidence and prevalence denote the evolution of IBD across four epidemiologic stages: stage 1 (emergence), characterized by low incidence and prevalence; stage 2 (acceleration in incidence), marked by rapidly rising incidence and low prevalence; and stage 3 (compounding prevalence), where the incidence decelerates, plateaus or declines while the prevalence steadily increases. A fourth stage (prevalence equilibrium) has been proposed in which the prevalence slope plateaus due to demographic shifts in an ageing IBD population, but it has not yet been evidenced. To date, these stages have remained theoretical, lacking specific numerical indicators to define transition points. Here, using real-world data from 522 population-based studies encompassing 82 global regions and spanning more than a century (1920–2024), we show spatiotemporal transitions across stages 1–3 and model stage 4 progression. Understanding the evolution of IBD across epidemiologic stages enables healthcare systems to better anticipate the future worldwide burden of IBD. An analysis of data from 522 population-based studies encompassing 82 global regions and spanning more than a century (1920–2024) shows spatiotemporal transitions across epidemiologic stages 1 to 3 of inflammatory bowel disease, and models stage 4 progression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41586-025-08940-0

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 55 references

Metadata

Authors
Hracs, L., Windsor, J. W., Gorospe, J., Cummings, M., Coward, S., Buie, M. J., Quan, J., Goddard, Q., Caplan, L., Markovinović, A., Williamson, T., Abbey, Y., Abdullah, M., Abreu, M. T., Ahuja, V., Raja Ali, R. A., Altuwaijri, M., Balderramo, D., Banerjee, R., Benchimol, E. I., Bernstein, C. N., Brunet-Mas, E., Burisch, J., Chong, V. H., Dotan, I., Dutta, U., El Ouali, S., Forbes, A., Forss, A., Gearry, R., Dao, V. H., Hartono, J. L., Hilmi, I., Hodges, P., Jones, G.-R., Juliao-Baños, F., Kaibullayeva, J., Kelly, P., Kobayashi, T., Kotze, P. G., Lakatos, P. L., Lees, C. W., Limsrivilai, J., Lo, B., Loftus, E. V., Ludvigsson, J. F., Mak, J. W. Y., Miao, Y., Ng, K. K., Okabayashi, S., Olén, O., Panaccione, R., Paudel, M. S., Quaresma, A. B., Rubin, D. T., Simadibrata, M., Sun, Y., Suzuki, H., Toro, M., Turner, D., Iade, B., Wei, S. C., Yamamoto-Furusho, J. K., Yang, S.-K., Ng, S. C., Kaplan, G. G., & Global IBD Visualization of Epidemiology Studies in the 21st Century (GIVES-21) Research Group
Venue
Nature
Published
2025-04-30
Volume
642
Issue
8067
Pages
458-466
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W4410019431
Cited by
455
References
55
FWCI
246.17
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Global evolution of inflammatory bowel disease across epidemiologic stages. https://app.cochat.ai/papers/10.1038/s41586-025-08940-0
The paper
Hracs, L., Windsor, J. W., Gorospe, J., Cummings, M., Coward, S., Buie, M. J., Quan, J., Goddard, Q., Caplan, L., Markovinović, A., Williamson, T., Abbey, Y., Abdullah, M., Abreu, M. T., Ahuja, V., Raja Ali, R. A., Altuwaijri, M., Balderramo, D., Banerjee, R., . . . Global IBD Visualization of Epidemiology Studies in the 21st Century (GIVES-21) Research Group. (2025). Global evolution of inflammatory bowel disease across epidemiologic stages. Nature. https://doi.org/10.1038/s41586-025-08940-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.